Smith & Nephew plc (SN) Given New GBX 1,280 Price Target at JPMorgan Chase & Co.

Smith & Nephew plc (LON:SN) had its target price cut by stock analysts at JPMorgan Chase & Co. from GBX 1,345 ($17.36) to GBX 1,280 ($16.52) in a research note issued to investors on Monday, May 8th. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.’s target price suggests a potential downside of 3.54% from the stock’s current price.

SN has been the topic of several other reports. Goldman Sachs Group Inc restated a “neutral” rating and set a GBX 1,270 ($16.39) price target on shares of Smith & Nephew plc in a research note on Friday, May 5th. Numis Securities Ltd reiterated an “add” rating and issued a GBX 1,350 ($17.43) price objective on shares of Smith & Nephew plc in a research note on Friday, May 5th. Berenberg Bank lowered their price objective on Smith & Nephew plc from GBX 1,340 ($17.30) to GBX 1,275 ($16.46) and set a “hold” rating on the stock in a research note on Wednesday, February 15th. Deutsche Bank AG upped their price objective on Smith & Nephew plc from GBX 1,150 ($14.84) to GBX 1,200 ($15.49) and gave the company a “hold” rating in a research note on Monday, February 13th. Finally, Jefferies Group LLC reiterated a “buy” rating and issued a GBX 1,350 ($17.43) price objective on shares of Smith & Nephew plc in a research note on Friday, May 5th. Ten investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Smith & Nephew plc currently has an average rating of “Hold” and a consensus target price of GBX 1,279.58 ($16.52).

Analyst Recommendations for Smith & Nephew plc (LON:SN)

COPYRIGHT VIOLATION WARNING: This article was published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be accessed at https://www.chaffeybreeze.com/2017/05/20/smith-nephew-plc-sn-pt-lowered-to-gbx-1280-updated.html.

In related news, insider Olivier Bohuon sold 8,031 shares of the company’s stock in a transaction on Tuesday, March 7th. The shares were sold at an average price of GBX 1,222 ($15.77), for a total value of £98,138.82 ($126,679.77).

About Smith & Nephew plc

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

12 Month Chart for LON:SN

Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply